SMS Pharmaceuticals share news, announcements and annual reports
NSE: SMSPHARMABSE: 532815Pharmaceuticals & BiotechnologySmall Cap
SMS Pharmaceuticals Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 2007
Last close ₹475.45up ₹32.65 (7.37%)BSE ₹477.00
Share price at the NSE close on 28 Oct 2026. Previous close ₹442.80.
28 Oct: open ₹435.00, high ₹478.00, low ₹435.00
52-week range of traded prices to 28 Oct 2026
₹270.10Low, 24 Nov 2025₹494.45High, 22 Sep 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹4,453 Cr920th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 43.36
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.67
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.08%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 14.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 11.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.46
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 7,77,21443.9% delivered
SMS Pharmaceuticals has 714 announcements on record, routine notices left out; 2 in the 30 days to 29 Oct 2026, the latest on 28 Oct 2026.
Next board meeting and results date
As the company gave notice to the exchange.SMS Pharmaceuticals quarterly results
Nov4Wed
The board meets on 4 Nov 2026 to consider financial results
Notice filed 28 Oct 2026
To consider and approve the financial results for the period ended September 30, 2026
SMS Pharmaceuticals annual reports, presentations and earnings calls
The company's own documents, latest first.SMS Pharmaceuticals financials, year by year
Annual reports18
- Annual report, year to Mar 20264 Sep 2026
- Annual report, year to Mar 20256 Sep 2025
- Annual report, year to Mar 20246 Sep 2024
- Annual report, year to Mar 20237 Sep 2023, a zip file
- Annual report, year to Mar 20227 Sep 2022, a zip file
13 earlier reports
- Annual report, year to Mar 20218 Sep 2021, a zip file
- Annual report, year to Mar 20208 Sep 2020, a zip file
- Annual report, year to Mar 20197 Sep 2019, a zip file
- Annual report, year to Mar 201822 Oct 2018, a zip file
- Annual report, year to Mar 20175 Oct 2017, a zip file
- Annual report, year to Mar 20166 Oct 2016, a zip file
- Annual report, year to Mar 201514 Sep 2015, a zip file
- Annual report, year to Mar 20149 Sep 2014, a zip file
- Annual report, year to Mar 201319 Sep 2013, a zip file
- Annual report, year to Mar 201217 Sep 2012, a zip file
- Annual report, year to Mar 201112 Sep 2011, a zip file
- Annual report, year to Mar 201020 Sep 2010, a zip file
- Annual report, year to Mar 200922 Sep 2009, a zip file
Investor presentations21
- Investor Presentation1 Aug 2026
- Investor Presentation23 May 2026
- Investor Presentation9 Feb 2026
- Investor Presentation10 Nov 2025
- Investor Presentation10 Aug 2025
16 earlier presentations
- Investor Presentation31 May 2025
- Investor Presentation12 Feb 2025
- Investor Presentation12 Nov 2024
- Investor Presentation6 Aug 2024
- Investor Presentation30 May 2024
- Investor Presentation10 Feb 2024
- Investor Presentation9 Nov 2023
- Investor Presentation9 Aug 2023
- Investor Presentation25 May 2023
- Presentation9 Feb 2023
- Investor Presentation14 Nov 2022
- Investor Presentation13 Aug 2022
- Investor Presentation2 Jun 2022
- Press release and investor presentation10 Feb 2022
- Investor Presentation13 Nov 2021
- Investor Presentation28 Oct 2021
Earnings calls29
- Transcript30 May 2026
- Link of Recording27 May 2026
- Transcript13 Nov 2025
- Link of Recording11 Nov 2025
- Transcript5 Jun 2025
24 earlier call documents
- Link of Recording2 Jun 2025
- Transcript15 Nov 2024
- Link of Recording13 Nov 2024
- Transcript12 Aug 2024
- Link of Recording7 Aug 2024
- Transcript6 Jun 2024
- Link of Recording31 May 2024
- Transcript17 Feb 2024
- Link of Recording12 Feb 2024
- Transcript18 Nov 2023
- Link of Recording10 Nov 2023
- Transcript17 Aug 2023
- Link of Recording10 Aug 2023
- Transcript31 May 2023
- Link of Recording26 May 2023
- Transcript14 Feb 2023
- Link of Recording10 Feb 2023
- Transcript of Analysts/Institutional Investor Meet/Con. Call23 Nov 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call17 Nov 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call23 Aug 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call18 Aug 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call9 Jun 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call6 Jun 2022
- Earnings call Transcript Q2 FY2223 Nov 2021
SMS Pharmaceuticals merger and demerger filings
Filings about a merger, demerger or scheme of arrangement, latest first.
Filings6
- Intimation of effective date of Scheme of Arrangement18 May 2017, a zip file
- Approval of Scheme of Arrangement between M/s. SMS Pharmaceuticals Limited (Demerged/ Transferor/ Petitioner Company) and M/s. SMS Lifesciences India Limited (Resulting/ Transferee/ Petitioner Company) and their respective Shareholders and Creditors.16 May 2017, a zip file
- Scheme of arrangement between SMS Pharmaceuticals Limited and SMS Lifesciences India Limited and their respective Shareholders and Creditors17 Feb 2017, a zip file
- Updates on Scheme of Arrangement.16 Nov 2016, a zip file
- Scheme of Arrangement in nature of Demerger between SMS Pharmaceuticals Limited (Demerged Company) & SMS Lifesciences India Limited (Resulting Company) and their respective Shareholders and Creditors under Section 391 394 of the Companies Act, 1956 and other applicable provisions, if any of the Companies Act, 1956 and Companies Act, 2013. ( "Scheme" )17 Aug 2016, a zip file
SMS Pharmaceuticals share news and announcements
Newest first. Page 1 of 15.
Oct 2026
28 Oct · Board meeting
Sep 2026
29 Sep · Meeting
10 Sep · Analysts
4 Sep · Updates
2 Sep · Rating
Aug 2026
27 Aug · General Updates
6 Aug · Updates
Jul 2026
31 Jul · Results
25 Jul · Board meeting
Not held on this date
22 Jul
20 Jul
1 Jul · Legal
The exchange asked on 30 Jun 2026
Jun 2026
5 Jun
May 2026
23 May
23 May · Business
22 May · Analysts
22 May · Results
15 May · Business
Apr 2026
30 Apr
29 Apr · Legal
Mar 2026
31 Mar · Legal
Feb 2026
10 Feb · Business
7 Feb · Business
7 Feb · Results
Jan 2026
Dec 2025
26 Dec · General Updates
24 Dec · General Updates
4 Dec · Rating
Nov 2025
26 Nov · Business
12 Nov · Business
8 Nov · Business
8 Nov · Results
7 Nov · Updates
5 Nov · Analysts
Oct 2025
Sep 2025
How the price met the news
The latest 30. The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 2 Sep 2026Credit ratingup 1.30%+1.8 pts vs Nifty 500market median 0.0% · five sessions +8.4% (+9.4 pts vs Nifty 500) · volume 1.0× usual · delivery −13.5 pts against usual · The announcement
- 3 Aug 2026Resultsdown 2.77%−4.2 pts vs Nifty 500market median −0.7% · five sessions +1.1% (+0.1 pts vs Nifty 500) · volume 1.4× usual · delivery +0.9 pts against usual · The announcement
- 22 May 2026Resultsdown 10.43%−10.6 pts vs Nifty 500market median −0.7% · five sessions −13.3% (−13.5 pts vs Nifty 500) · volume 8.4× usual · delivery −22.6 pts against usual · The announcement
- 9 Feb 2026Resultsup 0.69%−0.4 pts vs Nifty 500market median −0.7% · five sessions +6.0% (+6.5 pts vs Nifty 500) · volume 2.4× usual · delivery +1.6 pts against usual · The announcement
- 4 Dec 2025Credit ratingup 0.75%+0.6 pts vs Nifty 500market median 0.0% · five sessions −2.9% (−1.6 pts vs Nifty 500) · volume 0.5× usual · delivery −4.4 pts against usual · The announcement
- 10 Nov 2025Resultsup 1.26%+0.9 pts vs Nifty 500market median −0.7% · five sessions −1.4% (−2.7 pts vs Nifty 500) · volume 34.1× usual · delivery −31.8 pts against usual · The announcement
- 11 Aug 2025Resultsup 2.37%+1.5 pts vs Nifty 500market median −0.7% · five sessions +5.2% (+3.0 pts vs Nifty 500) · volume 2.0× usual · delivery −1.3 pts against usual · The announcement
- 2 Jun 2025Resultsdown 1.75%−1.9 pts vs Nifty 500market median −0.7% · five sessions −7.4% (−9.0 pts vs Nifty 500) · volume 2.2× usual · delivery −11.1 pts against usual · The announcement
- 12 Feb 2025Resultsup 5.76%+6.0 pts vs Nifty 500market median −0.7% · five sessions −7.2% (−5.6 pts vs Nifty 500) · volume 4.1× usual · delivery −23.9 pts against usual · The announcement
- 11 Nov 2024Resultsdown 5.02%−4.8 pts vs Nifty 500market median −0.7% · five sessions −14.0% (−10.7 pts vs Nifty 500) · volume 1.6× usual · delivery +4.2 pts against usual · The announcement
20 earlier announcements
- 5 Aug 2024Resultsdown 0.64%+2.4 pts vs Nifty 500market median −0.7% · five sessions −9.2% (−7.8 pts vs Nifty 500) · volume 3.2× usual · delivery −15.8 pts against usual · The announcement
- 30 May 2024Board or managers changeddown 6.07%−5.0 pts vs Nifty 500market median 0.0% · five sessions −10.4% (−9.5 pts vs Nifty 500) · volume 2.7× usual · delivery −1.1 pts against usual · The announcement
- 29 May 2024Resultsup 0.88%+1.5 pts vs Nifty 500market median −0.7% · five sessions −12.8% (−7.8 pts vs Nifty 500) · volume 7.6× usual · delivery −19.7 pts against usual · The announcement
- 29 May 2024Dividendup 0.88%+1.5 pts vs Nifty 500market median 0.0% · five sessions −12.8% (−7.8 pts vs Nifty 500) · volume 7.6× usual · delivery −19.7 pts against usual · The announcement
- 9 Feb 2024Resultsup 11.89%+12.0 pts vs Nifty 500market median −0.7% · five sessions +12.8% (+12.6 pts vs Nifty 500) · volume 44.3× usual · delivery −31.7 pts against usual · The announcement
- 8 Nov 2023Resultsup 0.54%+0.1 pts vs Nifty 500market median −0.7% · five sessions −1.3% (−2.1 pts vs Nifty 500) · volume 18.2× usual · delivery −22.9 pts against usual · The announcement
- 24 May 2023Resultsup 1.32%+1.5 pts vs Nifty 500market median −0.7% · five sessions −0.2% (−1.9 pts vs Nifty 500) · volume 20.2× usual · delivery −49.9 pts against usual · The announcement
- 24 May 2023Dividendup 1.32%+1.5 pts vs Nifty 500market median 0.0% · five sessions −0.2% (−1.9 pts vs Nifty 500) · volume 20.2× usual · delivery −49.9 pts against usual · The announcement
- 9 Feb 2023Resultsup 3.59%+3.6 pts vs Nifty 500market median −0.7% · five sessions −1.4% (−1.5 pts vs Nifty 500) · volume 5.5× usual · delivery −50.3 pts against usual · The announcement
- 14 Nov 2022Resultsdown 13.90%−13.9 pts vs Nifty 500market median −0.7% · five sessions −20.8% (−20.2 pts vs Nifty 500) · volume 5.8× usual · delivery −12.1 pts against usual · The announcement
- 4 Nov 2022Credit ratingup 0.40%+0.1 pts vs Nifty 500market median 0.0% · five sessions +18.3% (+17.3 pts vs Nifty 500) · volume 1.1× usual · delivery −5.4 pts against usual · The announcement
- 6 Oct 2022Credit ratingdown 1.21%−1.8 pts vs Nifty 500market median 0.0% · five sessions −2.6% (−1.7 pts vs Nifty 500) · volume 0.4× usual · delivery +13.7 pts against usual · The announcement
- 16 Aug 2022Resultsdown 6.20%−7.1 pts vs Nifty 500market median −0.7% · five sessions −7.8% (−6.9 pts vs Nifty 500) · volume 4.4× usual · delivery −1.1 pts against usual · The announcement
- 10 Aug 2022Board or managers changeddown 1.44%−1.4 pts vs Nifty 500market median 0.0% · five sessions −6.7% (−9.2 pts vs Nifty 500) · volume 0.2× usual · delivery +3.6 pts against usual · The announcement
- 30 May 2022Dividenddown 1.89%−3.9 pts vs Nifty 500market median 0.0% · five sessions −2.9% (−4.4 pts vs Nifty 500) · volume 2.1× usual · delivery −17.6 pts against usual · The announcement
- 30 May 2022Resultsdown 1.89%−3.9 pts vs Nifty 500market median −0.7% · five sessions −2.9% (−4.4 pts vs Nifty 500) · volume 2.1× usual · delivery −17.6 pts against usual · The announcement
- 9 Feb 2022Resultsdown 5.20%−6.3 pts vs Nifty 500market median −0.7% · five sessions −13.7% (−13.4 pts vs Nifty 500) · volume 2.0× usual · delivery −13.9 pts against usual · The announcement
- 12 Nov 2021Resultsup 0.51%−0.6 pts vs Nifty 500market median −0.7% · five sessions −3.7% (−3.0 pts vs Nifty 500) · volume 3.3× usual · delivery −25.5 pts against usual · The announcement
- 6 Sep 2021Credit ratingup 0.32%0.0 pts vs Nifty 500market median 0.0% · five sessions −5.6% (−6.3 pts vs Nifty 500) · volume 0.7× usual · delivery +11.0 pts against usual · The announcement
- 9 Aug 2021Resultsdown 3.32%−3.2 pts vs Nifty 500market median −0.7% · five sessions −6.2% (−7.0 pts vs Nifty 500) · volume 1.1× usual · delivery −5.2 pts against usual · The announcement
SMS Pharmaceuticals results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.